Skip to content

Clinical trials

Terminated Alzheimer Disease trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Status: Terminated Country / region: Russia Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20082
20091
20102
20121
20141
20151
20163
20171
20182
20201
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated17

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche6
AstraZeneca2
Pfizer2
AbbVie (prior sponsor, Abbott)1
Central Clinical Hospital of the Russian Academy of Sciences1
Eisai Co., Ltd.1
Eli Lilly and Company1
GlaxoSmithKline1
Janssen Research & Development, LLC1
TauRx Therapeutics Ltd1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease17
Dementia4
Brain Diseases3
Neurodegenerative Diseases3
Central Nervous System Diseases2
Cognitive Dysfunction2
Mental Disorders2
Nervous System Diseases2
Tauopathies2
Angina, Stable1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.